{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:12:32Z","timestamp":1779127952466,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ahj.2017.02.032","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T17:16:16Z","timestamp":1488820576000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure\u2014Trial design of the REDUCE FMR study"],"prefix":"10.1016","volume":"188","author":[{"given":"Steven L.","family":"Goldberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Haluska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Lipiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Siminiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawzer","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.02.032_bb0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0002-8703(91)90523-K","article-title":"Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus","volume":"122","author":"Blondheim","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.02.032_bb0010","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ejheart.2005.01.016","article-title":"Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure","volume":"7","author":"Cioffi","year":"2005","journal-title":"Eur J Heart Fail"},{"issue":"Suppl. F","key":"10.1016\/j.ahj.2017.02.032_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurheartj\/9.suppl_F.5","article-title":"Clinical significance of mitral regurgitation in patients with recent myocardial infarction","volume":"9","author":"De Servi","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.02.032_bb0020","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(09)60692-9","article-title":"Mitral regurgitation","volume":"373","author":"Enriquez-Sarano","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.02.032_bb0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jacc.2004.12.069","article-title":"Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST)","volume":"45","author":"Grayburn","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000175942","article-title":"The hemodynamic and prognostic significance of echo-Doppler\u2013proven mitral regurgitation in patients with dilated cardiomyopathy","volume":"83","author":"Junker","year":"1993","journal-title":"Cardiology"},{"key":"10.1016\/j.ahj.2017.02.032_bb0035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mhj.2002.123575","article-title":"Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction","volume":"144","author":"Koelling","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.02.032_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cardfail.2003.12.006","article-title":"Mitral regurgitation in patients with advanced systolic heart failure","volume":"10","author":"Patel","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2017.02.032_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-5273(96)02839-2","article-title":"Mild mitral regurgitation reduces exercise capacity in patients with idiopathic dilated cardiomyopathy","volume":"58","author":"Tada","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0050","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9149(02)03301-5","article-title":"Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure","volume":"91","author":"Trichon","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1067\/mhj.2002.123576","article-title":"Secondary mitral and tricuspid regurgitation accompanying left ventricular systolic dysfunction: is it important, and how is it treated?","volume":"144","author":"Trichon","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.02.032_bb0060","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of C","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.02.032_bb0065","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0070","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2014.06.1166","article-title":"Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry","volume":"64","author":"Nickenig","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0075","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2013.02.094","article-title":"Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe","volume":"62","author":"Maisano","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.109.849885","article-title":"Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study","volume":"120","author":"Schofer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.032_bb0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/eurjhf\/hfs076","article-title":"Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial","volume":"14","author":"Siminiak","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2017.02.032_bb0090","doi-asserted-by":"crossref","first-page":"e000411","DOI":"10.1136\/openhrt-2016-000411","article-title":"Coronary sinus-based percutaneous annuloplasty as treatment for functional mitral regurgitation: the TITAN II trial","volume":"3","author":"Lipiecki","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.ahj.2017.02.032_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12872-015-0039-8","article-title":"Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings","volume":"15","author":"Borisenko","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ahj.2017.02.032_bb0100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00392-015-0841-4","article-title":"Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons","volume":"104","author":"Ohlmeier","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0105","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","article-title":"A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease","volume":"46","author":"Leon","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.032_bb0110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.02.032_bb0115","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.02.032_bb0120","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomised controlled trial","volume":"376","author":"Symplicity","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.02.032_bb0125","series-title":"Clinical trial design principles and standardized endpoint definitions for transcatheter mitral valve repair and replacement. A consensus document from the Mitral Valve Academic Research Consortium, part 2: standardized ednpoint definitions","author":"Stone","year":"2015"},{"key":"10.1016\/j.ahj.2017.02.032_bb0130","series-title":"Clinical trial design principles and standardized endpoint definitions for transcatheter mitral valve repair and replacement. A consensus document from the Mitral Valve Academic Research Consortium, part 1: clinical trial design principles","author":"Stone","year":"2015"},{"key":"10.1016\/j.ahj.2017.02.032_bb0135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCULATIONAHA.108.773838","article-title":"Use of cardiac resynchronization therapy in patients hospitalized with heart failure","volume":"118","author":"Piccini","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.032_bb0140","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.02.032_bb0145","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","article-title":"Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigioni","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.032_bb0150","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ejechocard\/jeq031","article-title":"European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.ahj.2017.02.032_bb0155","first-page":"115","article-title":"Mitral annuloplasty device implantation for non-surgical treatment of mitral regurgitation: clinical experience after the approval studies","volume":"28","author":"Klein","year":"2016","journal-title":"J Invasive Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317300807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317300807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:48Z","timestamp":1757570328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317300807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"alternative-id":["S0002870317300807"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.02.032","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure\u2014Trial design of the REDUCE FMR study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}